Bio-Techne (TECH) Q3 2024 Earnings
TECH·Reported October 30, 2024·Before market open·FQ1 FY2025
Bio-Techne reported Q3 2024 revenue of $289.5M, beat analyst consensus of $280.3M by $9.2M. Diluted EPS came in at $0.42, beat the $0.38 consensus by $0.04.
Revenue
$289.5Mbeat by $9.2M
Consensus: $280.3MDiluted EPS
$0.42beat by $0.04
Consensus: $0.38
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Bio-Techne's Q3 2024 earnings report.
Bio-Techne (TECH) reported Q3 2024 earnings on October 30, 2024 before market open.
Bio-Techne reported revenue of $289.5M and diluted EPS of $0.42 for Q3 2024.
Revenue beat the consensus estimate of $280.3M by $9.2M. EPS beat the consensus estimate of $0.38 by $0.04.
You can read the 10-Q periodic report (0001558370-24-014439) directly on SEC EDGAR. The filing index links above go to sec.gov.